NO160297C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oksoazetidinderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oksoazetidinderivater

Info

Publication number
NO160297C
NO160297C NO814113A NO814113A NO160297C NO 160297 C NO160297 C NO 160297C NO 814113 A NO814113 A NO 814113A NO 814113 A NO814113 A NO 814113A NO 160297 C NO160297 C NO 160297C
Authority
NO
Norway
Prior art keywords
amino group
chem
oxoazetime
ingrediates
preparation
Prior art date
Application number
NO814113A
Other languages
English (en)
Norwegian (no)
Other versions
NO814113L (no
NO160297B (no
Inventor
Taisuke Matsuo
Hirotomo Masuya
Noriyoshi Noguchi
Michihiko Ochiai
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1980/000296 external-priority patent/WO1982001872A1/ja
Priority claimed from PCT/JP1981/000102 external-priority patent/WO1982003858A1/ja
Priority claimed from PCT/JP1981/000192 external-priority patent/WO1983000690A1/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO814113L publication Critical patent/NO814113L/no
Publication of NO160297B publication Critical patent/NO160297B/no
Publication of NO160297C publication Critical patent/NO160297C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO814113A 1980-12-05 1981-12-02 Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oksoazetidinderivater NO160297C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP1980/000296 WO1982001872A1 (en) 1980-12-05 1980-12-05 Azetidine derivatives and process for their preparation
PCT/JP1981/000102 WO1982003858A1 (fr) 1981-04-30 1981-04-30 Derives d'azetidine et procede de preparation
PCT/JP1981/000192 WO1983000690A1 (en) 1981-08-25 1981-08-25 Azetidine derivatives and process for their preparation

Publications (3)

Publication Number Publication Date
NO814113L NO814113L (no) 1982-06-07
NO160297B NO160297B (no) 1988-12-27
NO160297C true NO160297C (no) 1989-04-05

Family

ID=27303167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO814113A NO160297C (no) 1980-12-05 1981-12-02 Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oksoazetidinderivater

Country Status (26)

Country Link
US (1) US4822790A (sv)
EP (1) EP0053815B1 (sv)
JP (1) JPS57131759A (sv)
KR (1) KR880001564B1 (sv)
AT (3) AT379800B (sv)
AU (1) AU551463B2 (sv)
CH (1) CH656122A5 (sv)
DE (2) DE3170437D1 (sv)
DK (1) DK534381A (sv)
ES (2) ES507716A0 (sv)
FI (1) FI79528C (sv)
FR (1) FR2495612A1 (sv)
GB (1) GB2091723B (sv)
HU (1) HU189545B (sv)
IE (1) IE53451B1 (sv)
IL (1) IL64314A (sv)
IT (1) IT1146726B (sv)
LU (1) LU83820A1 (sv)
MX (1) MX7096E (sv)
NL (1) NL8105468A (sv)
NO (1) NO160297C (sv)
NZ (1) NZ199168A (sv)
PT (1) PT74087B (sv)
SE (1) SE8107273L (sv)
SU (2) SU1662348A3 (sv)
WO (1) WO1982002042A1 (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199828A (en) * 1981-03-30 1985-11-08 Squibb & Sons Inc 4-substituted mercapto-2-oxo-1-azetidine-sulphonic acid derivatives and pharmaceutical compositions
US4734496A (en) * 1981-05-29 1988-03-29 E. R. Squibb & Sons, Inc. 4-amino derivatives of 2-oxo-1-azetidinesulfonic acid salts
JPS588060A (ja) * 1981-06-29 1983-01-18 イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド アリ−ルチオアゼチジノンスルホン酸塩類
FR2509726B1 (sv) * 1981-07-16 1984-04-27 Squibb & Sons Inc
ATE24726T1 (de) * 1981-10-05 1987-01-15 Squibb & Sons Inc 4-aether-derivate von 2-azetidinon-1-sulfonsaeuren.
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
JPS58210060A (ja) * 1982-05-31 1983-12-07 Takeda Chem Ind Ltd 2−オキソアゼチジン誘導体、その製造法および用途
JPS5916888A (ja) * 1982-07-20 1984-01-28 Takeda Chem Ind Ltd 1−スルホ−2−アゼチジノン誘導体およびその製造法
US4681937A (en) * 1982-09-27 1987-07-21 E. R. Squibb & Sons, Inc. 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters
JPS59101485A (ja) * 1982-11-29 1984-06-12 Otsuka Chem Co Ltd アセチジノン誘導体
DE3342929A1 (de) * 1983-11-26 1985-06-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel
US4883869A (en) * 1984-12-20 1989-11-28 The Upjohn Company Novel beta-lactams containing amino acid substituents
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
KR890700586A (ko) * 1987-02-27 1989-04-25 로버어트 에이 아마테이지 피리돈 카르복실산 또는 산유도체를 함유하는 항균제 베타-락탐
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
EP0950046B1 (en) * 1996-09-23 2002-04-10 Naeja Pharmaceutical Inc. 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6046955B2 (ja) * 1977-12-30 1985-10-18 武田薬品工業株式会社 抗生物質g−6302
JPS5549394A (en) * 1978-10-03 1980-04-09 Takeda Chem Ind Ltd Antibiotic substance sb-72310
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
DE3064810D1 (en) * 1979-06-08 1983-10-20 Takeda Chemical Industries Ltd 3-methoxy-2-oxoazetidine derivatives and their production
EP0021678B1 (en) * 1979-06-08 1984-11-07 Takeda Chemical Industries, Ltd. 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof
NZ196202A (en) * 1980-02-07 1984-07-31 Squibb & Sons Inc Beta-lactam antibiotics (of azetidine-sulphonic acid type)
NZ199828A (en) * 1981-03-30 1985-11-08 Squibb & Sons Inc 4-substituted mercapto-2-oxo-1-azetidine-sulphonic acid derivatives and pharmaceutical compositions
JPS588060A (ja) * 1981-06-29 1983-01-18 イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド アリ−ルチオアゼチジノンスルホン酸塩類
FR2509726B1 (sv) * 1981-07-16 1984-04-27 Squibb & Sons Inc
FR2515182B1 (fr) * 1981-10-23 1986-05-09 Roussel Uclaf Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation

Also Published As

Publication number Publication date
ES513420A0 (es) 1983-04-01
ES8301915A1 (es) 1982-12-16
KR830007549A (ko) 1983-10-21
WO1982002042A1 (en) 1982-06-24
NZ199168A (en) 1985-08-30
ES507716A0 (es) 1982-12-16
AT379800B (de) 1986-02-25
AU551463B2 (en) 1986-05-01
IE53451B1 (en) 1988-11-23
KR880001564B1 (ko) 1988-08-22
LU83820A1 (fr) 1982-05-07
PT74087B (en) 1983-05-23
SU1531852A3 (ru) 1989-12-23
MX7096E (es) 1987-06-19
GB2091723A (en) 1982-08-04
US4822790A (en) 1989-04-18
ATE13178T1 (de) 1985-05-15
FI79528C (sv) 1990-01-10
FR2495612A1 (fr) 1982-06-11
IE812859L (en) 1982-06-05
ATA520781A (de) 1985-07-15
PT74087A (en) 1982-01-01
FR2495612B1 (sv) 1984-06-01
NL8105468A (nl) 1982-07-01
AU7831381A (en) 1982-06-10
IT1146726B (it) 1986-11-19
JPS57131759A (en) 1982-08-14
IL64314A0 (en) 1982-02-28
IL64314A (en) 1988-06-30
HU189545B (en) 1986-07-28
SU1662348A3 (ru) 1991-07-07
CH656122A5 (de) 1986-06-13
EP0053815A1 (en) 1982-06-16
FI79528B (fi) 1989-09-29
NO814113L (no) 1982-06-07
AT380471B (de) 1986-05-26
IT8168585A0 (it) 1981-12-04
FI813851L (fi) 1982-06-06
DE3148020A1 (de) 1982-10-21
ATA170384A (de) 1985-10-15
ES8305325A1 (es) 1983-04-01
SE8107273L (sv) 1982-06-06
DE3170437D1 (en) 1985-06-13
EP0053815B1 (en) 1985-05-08
NO160297B (no) 1988-12-27
GB2091723B (en) 1985-06-12
DK534381A (da) 1982-06-06

Similar Documents

Publication Publication Date Title
NO160297C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oksoazetidinderivater
NO900306L (no) Fremgangsmaate for fremstilling av nye pyrazolopyridin-forbindelser.
PT87700A (pt) Process for the preparation of a new pyrazolopyridine compound
NO914558L (no) Fremstilling og anvendelse av kondenserte heterocykliske forbindelse
HU9603433D0 (en) Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof
NO890996L (no) Fremgangsmaate for fremstilling av cefemforbindelser.
NO174886C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidin-derivater